Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer

BACKGROUND: Numerous chemotherapeutic agents have antitumor activity in recurrent/metastatic (R/M) nasopharyngeal cancer (NPC). Evidence of capecitabine's effectiveness as monotherapy is limited. Capecitabine tolerability in solid malignancies has ethnic and geographical variability. We investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshamsan, Bader, Gad, Ahmed Mostafa, Alata, Maaz Kamal, Alzahrani, Mashari, Elhassan, Tusneem, Atallah, Jean Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005308/
https://www.ncbi.nlm.nih.gov/pubmed/35422860
http://dx.doi.org/10.1155/2022/6860413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005308/
https://www.ncbi.nlm.nih.gov/pubmed/35422860
http://dx.doi.org/10.1155/2022/6860413

Ejemplares similares